Home LiteratureArticle Details
PMID: 20009134 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Intramural

NASH and cryptogenic cirrhosis: a histological analysis.

Annals of hepatology ·Vol. 8 ·No. 4 ·2009-00-00 ·Pages 346-52

Caldwell SH, Lee VD, Kleiner DE, Al-Osaimi AM, Argo CK, Northup PG, Berg CL

Abstract

Epidemiological studies indicate that nonalcoholic steatohepatitis (NASH) is a common cause of cirrhosis described as 'cryptogenic'. To address this from a histological perspective and to examine the significance of residual histological findings as an indication of prior NASH, we looked back at biopsies in patients who presented with cirrhosis without sufficient histological features to diagnose NASH but who had prior histologically confirmed non-cirrhotic NASH. Seven patients were identified with biopsy pairs showing non-specific (cryptogenic) cirrhosis in the latest specimen and a prior biopsy showing non-cirrhotic NASH. Using an expanded NASH-CRN system scored blindly by light microscopy, we compared the early and late biopsies to each other and to a cohort of 13 patients with cirrhosis due to hepatitis C without co-existing metabolic syndrome. Macrosteatosis, although uniformly present in the non-cirrhotic NASH specimens, declined in the late stage cirrhotic NASH specimens and was not useful in the distinction of late cirrhotic NASH from cirrhotic viral hepatitis. However, the presence of ballooned cells, Mallory-Denk bodies, and megamitochondria and the absence of apoptotic bodies were significantly different in late stage cirrhotic NASH compared to cirrhosis due to hepatitis C. Histologically advanced NASH presenting as non-specific or cryptogenic cirrhosis has residual changes which are consistent with prior steatohepatitis but which differ from cirrhosis due to hepatitis C. These results provide histological support for the more established epidemiological associations of NASH with cryptogenic cirrhosis and for criteria used in several proposed classifications of cryptogenic cirrhosis.

MeSH Terms
Adult Apoptosis Biopsy Diagnosis, Differential Disease Progression Fatty Liver/complications,diagnosis,pathology Female Hepatitis C/complications,diagnosis,pathology Humans Liver/pathology Liver Cirrhosis/diagnosis,etiology,pathology Male Middle Aged Mitochondria/pathology
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Caldwell Stephen H
Division of Gastroenterology and Hepatology, Digestive Health Center, University of Virginia, Charlottesville, Virginia 22908, USA. [email protected]
Lee Vanessa D
Kleiner David E
Al-Osaimi Abdullah M S
Argo Curtis K
Northup Patrick G
Berg Carl L
References (27)
27 references, click to expand
  1. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.
    Hum Pathol. 2002 Nov;33(11):1098-104 PMID: 12454814
  2. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.
    Hepatology. 2000 Oct;32(4 Pt 1):689-92 PMID: 11003611
  3. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
    Liver Transpl. 2001 Apr;7(4):363-73 PMID: 11303298
  4. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis.
    Liver Transpl. 2003 Sep;9(9):921-8 PMID: 12942453
  5. Nonalcoholic steatohepatitis: an expanded clinical entity.
    Gastroenterology. 1994 Oct;107(4):1103-9 PMID: 7523217
  6. Cryptogenic cirrhosis and NAFLD: are they related?
    Am J Gastroenterol. 2006 Mar;101(3):664-8 PMID: 16464222
  7. Long-term follow-up of patients with NAFLD and elevated liver enzymes.
    Hepatology. 2006 Oct;44(4):865-73 PMID: 17006923
  8. The effect of graded steatosis on flow in the hepatic parenchymal microcirculation.
    Transplantation. 1999 Sep 27;68(6):780-4 PMID: 10515377
  9. Two cases from the spectrum of nonalcoholic steatohepatitis.
    J Clin Gastroenterol. 1995 Mar;20(2):127-30 PMID: 7769192
  10. Focal sparing of segment IV in fatty livers shown by sonography and CT: correlation with aberrant gastric venous drainage.
    AJR Am J Roentgenol. 1995 May;164(5):1137-40 PMID: 7717220
  11. Thiazolidinediones for the treatment in NASH: sustained benefit after drug discontinuation?
    J Clin Gastroenterol. 2009 Jul;43(6):565-8 PMID: 19318980
  12. Nonalcoholic steatohepatitis: a study of 49 patients.
    Hum Pathol. 1989 Jun;20(6):594-8 PMID: 2656500
  13. Histological progression of non-alcoholic fatty liver disease in Chinese patients.
    Aliment Pharmacol Ther. 2005 Feb 15;21(4):407-13 PMID: 15709991
  14. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
    Hepatology. 2005 Jun;41(6):1313-21 PMID: 15915461
  15. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.
    Hepatology. 1999 Mar;29(3):664-9 PMID: 10051466
  16. Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow.
    J Clin Endocrinol Metab. 1984 Jun;58(6):1125-32 PMID: 6373811
  17. Nonalcoholic fatty liver disease.
    N Engl J Med. 2002 Apr 18;346(16):1221-31 PMID: 11961152
  18. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.
    Hepatology. 1990 Jan;11(1):74-80 PMID: 2295475
  19. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.
    Hepatology. 2009 Mar;49(3):809-20 PMID: 19142989
  20. Pathology of nonalcoholic fatty liver disease.
    Am J Clin Pathol. 2007 Nov;128(5):837-47 PMID: 17951208
  21. Ethnic differences in the prevalence of cryptogenic cirrhosis.
    Am J Gastroenterol. 2004 Feb;99(2):292-8 PMID: 15046220
  22. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.
    J Hepatol. 2009 Aug;51(2):371-9 PMID: 19501928
  23. The natural history of nonalcoholic fatty liver disease: a population-based cohort study.
    Gastroenterology. 2005 Jul;129(1):113-21 PMID: 16012941
  24. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease.
    Am J Pathol. 2003 Oct;163(4):1301-11 PMID: 14507639
  25. Liver fibrosis in overweight patients.
    Gastroenterology. 2000 Jun;118(6):1117-23 PMID: 10833486
  26. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.
    Arch Intern Med. 2003 Feb 24;163(4):427-36 PMID: 12588201
  27. Distinct enzyme profiles in patients with cryptogenic cirrhosis reflect heterogeneous causes with different outcomes after liver transplantation (OLT): a long-term documentation before and after OLT.
    Transplantation. 2002 Sep 27;74(6):792-8 PMID: 12364857
Article Info
Journal
Annals of hepatology
Abbr.
Ann Hepatol
ISSN
1665-2681
Published
2009-00-00
Pages
346-52
Language
English
Region
Mexico
NLM ID
101155885
PMCID
PMC8381243
Subset
IM
Grants
NIDDK NIH HHS · P30 DK067629 · United States
Intramural NIH HHS · ZIC BC010685 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]